-
Mashup Score: 34New Philips Mini TEE ultrasound transducer helps improve cardiac care for more patients - 6 day(s) ago
January 31, 2023 Latest innovation has the potential to reduce anesthesia during minimally invasive procedures [1] As a pioneer and leading innovator…
Source: www.globenewswire.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 4
Deal Provides Cytokinetics with Diversified Access to Capital as Company Advances Its Specialty Cardiology Franchise…
Source: www.globenewswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4
Deal Provides Cytokinetics with Diversified Access to Capital as Company Advances Its Specialty Cardiology Franchise…
Source: www.globenewswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1
PRESS RELEASE A NEW PUBLICATION IN THE MEDICAL JOURNAL MUSCLE & NERVE VALIDATES THE USE OF THE RATE OF DECLINE OF ALSFRS-R SCORE (ΔFS) FOR THE DESIGN…
Source: www.globenewswire.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 1
LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve…
Source: www.globenewswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3
This event is supported by Pfizer, Exelixis and Regeneron…
Source: www.globenewswire.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 7ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure - 1 month(s) ago
ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure …
Source: www.globenewswire.comCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 3Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS) - 1 month(s) ago
MENLO PARK, Calif., April 15, 2024 (GLOBE NEWSWIRE) — Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the…
Source: www.globenewswire.comCategories: General Medicine News, Rare DiseaseTweet
-
Mashup Score: 2Regeneron Ventures Launches with $500 Million Commitment to Fuel Promising Biotechnology Innovation - 1 month(s) ago
GREENWICH, Conn., April 15, 2024 (GLOBE NEWSWIRE) — Regeneron Ventures announces its formation as a venture capital fund focused on promising…
Source: www.globenewswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 15Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic Sclerosis - 2 month(s) ago
PHILADELPHIA, March 20, 2024 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and…
Source: www.globenewswire.comCategories: General Medicine News, General HCPsTweet
Our #ASEIRTPartner, @Philips, announced that its latest TEE transducer, designed to serve more patients with improved overall comfort, has received FDA 510(k) clearance. Read their press release: https://t.co/ovfz4kot83 https://t.co/1SpMyEFZlo